{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:22:19Z","timestamp":1774862539054,"version":"3.50.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jhep.2025.06.030","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:57:08Z","timestamp":1752580628000},"page":"e196-e198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fulminant tumour lysis syndrome after nivolumab and ipilimumab treatment for hepatocellular carcinoma"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3928-1471","authenticated-orcid":false,"given":"Gin Wai","family":"Kwok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3144-3389","authenticated-orcid":false,"given":"Tiffany Hoi Wing","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7114-0305","authenticated-orcid":false,"given":"Thomas","family":"Yau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10492","key":"10.1016\/j.jhep.2025.06.030_bib1","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(25)00403-9","article-title":"Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial","volume":"405","author":"Yau","year":"2025","journal-title":"The Lancet"},{"issue":"10","key":"10.1016\/j.jhep.2025.06.030_bib2","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.21037\/tcr-20-1158","article-title":"Successful treatment of acute tumor lysis syndrome associated with transcatheter chemoembolization with large hepatocellular carcinomas: two case reports","volume":"9","author":"Wang","year":"2020","journal-title":"Translational Cancer Res"},{"issue":"2","key":"10.1016\/j.jhep.2025.06.030_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s12328-020-01306-1","article-title":"Lenvatinib-induced tumor lysis syndrome in a patient with advanced hepatocellular carcinoma: a case report","volume":"14","author":"Shimizu","year":"2021","journal-title":"Clin J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhep.2025.06.030_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.hemonc.2018.03.004","article-title":"Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma","volume":"13","author":"Imam","year":"2020","journal-title":"Hematology\/Oncology Stem Cell Ther"},{"issue":"19","key":"10.1016\/j.jhep.2025.06.030_bib5","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard","year":"2011","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.jhep.2025.06.030_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/cia2.12148","article-title":"Tumor lysis syndrome and collateral immune activation in dual checkpoint blockade","volume":"4","author":"Konishi","year":"2021","journal-title":"J Cutan Immunol Allergy"},{"issue":"1","key":"10.1016\/j.jhep.2025.06.030_bib7","doi-asserted-by":"crossref","DOI":"10.21767\/2254-6081.1000127","article-title":"Tumor lysis syndrome following a single atezolizumab infusion for metastatic urothelial carcinoma involving both upper and lower tract","volume":"5","author":"Brunnhoelzl","year":"2017","journal-title":"Arch Cancer Res"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825023311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825023311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:39:45Z","timestamp":1774859985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825023311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0168827825023311"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.06.030","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fulminant tumour lysis syndrome after nivolumab and ipilimumab treatment for hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}